Experts' consensus on severe acute respiratory syndrome coronavirus-2 vaccination in adult patients with hematological diseases in China (2022)
成人血液病患者接种新型冠状病毒疫苗中国专家共识(2022年版)(151418)
Chinese guidelines for diagnosis and treatment of myelodysplastic syndromes (2019)
骨髓增生异常综合征中国诊断与治疗指南(2019年版)(125134)
Chinese guideline on the diagnosis and management of adult primary immune thrombocytopenia (version 2020)
成人原发免疫性血小板减少症诊断与治疗中国指南(2020年版)(99114)
Chinese guidelines for the diagnosis and treatment of adult acute myeloid leukemia (not APL) (2021)
中国成人急性髓系白血病(非急性早幼粒细胞白血病)诊疗指南(2021年版)(91061)
Chinese guidelines for diagnosis and treatment of adult acute lymphoblastic leukemia (2021)
中国成人急性淋巴细胞白血病诊断与治疗指南(2021年版)(81057)
Chinese guidelines for the clinical application of antibacterial drugs for agranulocytosis with fever (2020)
中国中性粒细胞缺乏伴发热患者抗菌药物临床应用指南(2020年版)(67390)
Following initial peer review, articles judged worthy of further consideration often require revisions, including additional experimentation. However, articles requiring extensive revisions will be at a disadvantage. Revised manuscripts should be received within 2 months of the date on the initial decision e-mail or they will be considered as a new submission, with a separate manuscript number and submission fee. An extension beyond this 2-month period may be granted in order to complete time-consuming new experiments requested by the reviewers, but such extensions must be requested from the Associate Editor at least 2 weeks before the end of the 2-month revision deadline.
If there are any changes to the manuscript’s authorship after the original submission (such as the addition or deletion of an author or a change in the order of authorship), contact the to Editorial office to request a change of authorship form.
Make sure all revisions are marked in the text document by using tools such as underlining, highlighting, and strike-through. Revisions marked using Microsoft Word Track Changes will not appear in the converted PDF and will be returned to the corresponding author.